IMS Health Holdings, Inc. (NYSE: IMS) Stock Competitors & Peer Comparison

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while GEHCV trades at $56.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas GEHCV's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, IMS is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for IMS.Check GEHCV's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, BTSG has a market cap of 12.1B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while BTSG trades at $61.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas BTSG's P/E ratio is 49.54. In terms of profitability, IMS's ROE is +0.27%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, IMS is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for IMS.Check BTSG's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, BTSGU has a market cap of 11.9B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while BTSGU trades at $199.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas BTSGU's P/E ratio is 183.15. In terms of profitability, IMS's ROE is +0.27%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, IMS is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for IMS.Check BTSGU's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, TEM has a market cap of 11.3B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while TEM trades at $64.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas TEM's P/E ratio is -129.32. In terms of profitability, IMS's ROE is +0.27%, compared to TEM's ROE of -0.55%. Regarding short-term risk, IMS is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for IMS.Check TEM's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SGFY trades at $30.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas SGFY's P/E ratio is 70.91. In terms of profitability, IMS's ROE is +0.27%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, IMS is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for IMS.Check SGFY's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, HQY has a market cap of 8.3B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while HQY trades at $98.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas HQY's P/E ratio is 23.08. In terms of profitability, IMS's ROE is +0.27%, compared to HQY's ROE of +0.11%. Regarding short-term risk, IMS is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for IMS.Check HQY's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, TXG has a market cap of 8B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while TXG trades at $63.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas TXG's P/E ratio is -107.15. In terms of profitability, IMS's ROE is +0.27%, compared to TXG's ROE of -0.09%. Regarding short-term risk, IMS is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for IMS.Check TXG's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, HNGE has a market cap of 7B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while HNGE trades at $90.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas HNGE's P/E ratio is 48.58. In terms of profitability, IMS's ROE is +0.27%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, IMS is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for IMS.Check HNGE's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, RCM has a market cap of 6B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while RCM trades at $14.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas RCM's P/E ratio is -102.21. In terms of profitability, IMS's ROE is +0.27%, compared to RCM's ROE of +0.00%. Regarding short-term risk, IMS is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for IMS.Check RCM's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, DOCS has a market cap of 5.1B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while DOCS trades at $27.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas DOCS's P/E ratio is 17.71. In terms of profitability, IMS's ROE is +0.27%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, IMS is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for IMS.Check DOCS's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, WAY has a market cap of 5B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while WAY trades at $26.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas WAY's P/E ratio is 17.27. In terms of profitability, IMS's ROE is +0.27%, compared to WAY's ROE of +0.04%. Regarding short-term risk, IMS is less volatile compared to WAY. This indicates lower risk in terms of short-term price fluctuations for IMS.Check WAY's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, HTFL has a market cap of 4.3B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while HTFL trades at $49.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas HTFL's P/E ratio is -24.73. In terms of profitability, IMS's ROE is +0.27%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, IMS is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for IMS.Check HTFL's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while ONEM trades at $16.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas ONEM's P/E ratio is -7.77. In terms of profitability, IMS's ROE is +0.27%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, IMS is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for IMS.Check ONEM's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, PRVA has a market cap of 2.6B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while PRVA trades at $20.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas PRVA's P/E ratio is 98.43. In terms of profitability, IMS's ROE is +0.27%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, IMS is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for IMS.Check PRVA's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while NXGN trades at $23.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas NXGN's P/E ratio is -266.00. In terms of profitability, IMS's ROE is +0.27%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, IMS is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for IMS.Check NXGN's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, OMCL has a market cap of 1.6B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while OMCL trades at $34.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas OMCL's P/E ratio is 18.23. In terms of profitability, IMS's ROE is +0.27%, compared to OMCL's ROE of +0.03%. Regarding short-term risk, IMS is more volatile compared to OMCL. This indicates higher risk in terms of short-term price fluctuations for IMS.Check OMCL's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while AGTI trades at $10.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas AGTI's P/E ratio is -71.79. In terms of profitability, IMS's ROE is +0.27%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, IMS is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for IMS.Check AGTI's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, OMDA has a market cap of 1.3B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while OMDA trades at $22.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas OMDA's P/E ratio is 318.43. In terms of profitability, IMS's ROE is +0.27%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, IMS is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for IMS.Check OMDA's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, CERT has a market cap of 1.3B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CERT trades at $8.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas CERT's P/E ratio is 20.33. In terms of profitability, IMS's ROE is +0.27%, compared to CERT's ROE of -0.07%. Regarding short-term risk, IMS is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for IMS.Check CERT's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while GDRX trades at $3.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas GDRX's P/E ratio is 11.03. In terms of profitability, IMS's ROE is +0.27%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, IMS is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for IMS.Check GDRX's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, TDOC has a market cap of 1.2B. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while TDOC trades at $6.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas TDOC's P/E ratio is -6.55. In terms of profitability, IMS's ROE is +0.27%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, IMS is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for IMS.Check TDOC's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, HSTM has a market cap of 868.9M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while HSTM trades at $29.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas HSTM's P/E ratio is 41.31. In terms of profitability, IMS's ROE is +0.27%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, IMS is less volatile compared to HSTM. This indicates lower risk in terms of short-term price fluctuations for IMS.Check HSTM's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CCLDO trades at $27.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas CCLDO's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, IMS is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for IMS.Check CCLDO's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, SOPH has a market cap of 696.3M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SOPH trades at $8.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas SOPH's P/E ratio is -7.48. In terms of profitability, IMS's ROE is +0.27%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, IMS is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for IMS.Check SOPH's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, PHR has a market cap of 688M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while PHR trades at $11.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas PHR's P/E ratio is 39.75. In terms of profitability, IMS's ROE is +0.27%, compared to PHR's ROE of +0.04%. Regarding short-term risk, IMS is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for IMS.Check PHR's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, CTEV has a market cap of 664.7M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CTEV trades at $39.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas CTEV's P/E ratio is -2.29. In terms of profitability, IMS's ROE is +0.27%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, IMS is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for IMS.Check CTEV's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while MPLN-WT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, IMS is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for IMS.Check MPLN-WT's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while ACCD trades at $7.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas ACCD's P/E ratio is -3.08. In terms of profitability, IMS's ROE is +0.27%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, IMS is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for IMS.Check ACCD's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SHCR trades at $1.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas SHCR's P/E ratio is -3.76. In terms of profitability, IMS's ROE is +0.27%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, IMS is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for IMS.Check SHCR's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, EVH has a market cap of 479.7M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while EVH trades at $4.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas EVH's P/E ratio is 32.81. In terms of profitability, IMS's ROE is +0.27%, compared to EVH's ROE of -0.99%. Regarding short-term risk, IMS is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for IMS.Check EVH's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, NRC has a market cap of 478.9M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while NRC trades at $21.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas NRC's P/E ratio is 25.91. In terms of profitability, IMS's ROE is +0.27%, compared to NRC's ROE of +0.48%. Regarding short-term risk, IMS is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for IMS.Check NRC's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SLGC trades at $2.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas SLGC's P/E ratio is -3.04. In terms of profitability, IMS's ROE is +0.27%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, IMS is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for IMS.Check SLGC's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SLGCW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, IMS's ROE is +0.27%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, IMS is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for IMS.Check SLGCW's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while TBRG trades at $26.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas TBRG's P/E ratio is 9.37. In terms of profitability, IMS's ROE is +0.27%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, IMS is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for IMS.Check TBRG's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while MPLN trades at $23.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas MPLN's P/E ratio is -0.23. In terms of profitability, IMS's ROE is +0.27%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, IMS is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for IMS.Check MPLN's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, SY has a market cap of 370M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SY trades at $2.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas SY's P/E ratio is -8.55. In terms of profitability, IMS's ROE is +0.27%, compared to SY's ROE of -0.16%. Regarding short-term risk, IMS is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for IMS.Check SY's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while TRHC trades at $10.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas TRHC's P/E ratio is -4.27. In terms of profitability, IMS's ROE is +0.27%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, IMS is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for IMS.Check TRHC's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SMFR trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas SMFR's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, IMS is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for IMS.Check SMFR's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, AMWL has a market cap of 224.3M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while AMWL trades at $13.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas AMWL's P/E ratio is -2.98. In terms of profitability, IMS's ROE is +0.27%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, IMS is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for IMS.Check AMWL's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, SPOK has a market cap of 223.1M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SPOK trades at $10.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas SPOK's P/E ratio is 17.80. In terms of profitability, IMS's ROE is +0.27%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, IMS is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for IMS.Check SPOK's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, LFMDP has a market cap of 160.2M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while LFMDP trades at $23.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas LFMDP's P/E ratio is -724.19. In terms of profitability, IMS's ROE is +0.27%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, IMS is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for IMS.Check LFMDP's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, OPRX has a market cap of 149.2M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while OPRX trades at $7.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas OPRX's P/E ratio is 7.29. In terms of profitability, IMS's ROE is +0.27%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, IMS is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for IMS.Check OPRX's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, LFMD has a market cap of 147.5M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while LFMD trades at $3.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas LFMD's P/E ratio is -6.10. In terms of profitability, IMS's ROE is +0.27%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, IMS is less volatile compared to LFMD. This indicates lower risk in terms of short-term price fluctuations for IMS.Check LFMD's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CPSI trades at $9.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas CPSI's P/E ratio is -183.80. In terms of profitability, IMS's ROE is +0.27%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, IMS is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for IMS.Check CPSI's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, HCAT has a market cap of 126.4M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while HCAT trades at $1.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas HCAT's P/E ratio is 8.55. In terms of profitability, IMS's ROE is +0.27%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, IMS is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for IMS.Check HCAT's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while AUGX trades at $2.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas AUGX's P/E ratio is -4.99. In terms of profitability, IMS's ROE is +0.27%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, IMS is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for IMS.Check AUGX's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, DH has a market cap of 109.7M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while DH trades at $1.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas DH's P/E ratio is 4.00. In terms of profitability, IMS's ROE is +0.27%, compared to DH's ROE of -0.79%. Regarding short-term risk, IMS is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for IMS.Check DH's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, CCLD has a market cap of 95.2M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CCLD trades at $2.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas CCLD's P/E ratio is 8.62. In terms of profitability, IMS's ROE is +0.27%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, IMS is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for IMS.Check CCLD's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, WORX has a market cap of 88M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while WORX trades at $5.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas WORX's P/E ratio is -6.40. In terms of profitability, IMS's ROE is +0.27%, compared to WORX's ROE of -0.35%. Regarding short-term risk, IMS is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for IMS.Check WORX's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while FORA trades at $2.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas FORA's P/E ratio is -24.11. In terms of profitability, IMS's ROE is +0.27%, compared to FORA's ROE of -0.17%. Regarding short-term risk, IMS is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for IMS.Check FORA's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CCLDP trades at $19.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas CCLDP's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, IMS is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for IMS.Check CCLDP's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SNCE trades at $5.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas SNCE's P/E ratio is -0.27. In terms of profitability, IMS's ROE is +0.27%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, IMS is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for IMS.Check SNCE's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while AKLI trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas AKLI's P/E ratio is -0.71. In terms of profitability, IMS's ROE is +0.27%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, IMS is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for IMS.Check AKLI's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, ONMD has a market cap of 34M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while ONMD trades at $0.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas ONMD's P/E ratio is -3.73. In terms of profitability, IMS's ROE is +0.27%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, IMS is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for IMS.Check ONMD's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SHLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas SHLT's P/E ratio is -3.87. In terms of profitability, IMS's ROE is +0.27%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, IMS is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for IMS.Check SHLT's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SHCRW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, IMS's ROE is +0.27%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, IMS is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for IMS.Check SHCRW's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, ONMDW has a market cap of 24.9M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while ONMDW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas ONMDW's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, IMS is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for IMS.Check ONMDW's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while STRM trades at $5.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas STRM's P/E ratio is -2.40. In terms of profitability, IMS's ROE is +0.27%, compared to STRM's ROE of -0.65%. Regarding short-term risk, IMS is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for IMS.Check STRM's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while RNLX trades at $0.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas RNLX's P/E ratio is -0.33. In terms of profitability, IMS's ROE is +0.27%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, IMS is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for IMS.Check RNLX's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while LIFW trades at $3.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas LIFW's P/E ratio is -0.02. In terms of profitability, IMS's ROE is +0.27%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, IMS is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for IMS.Check LIFW's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while BBLN trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas BBLN's P/E ratio is -0.04. In terms of profitability, IMS's ROE is +0.27%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, IMS is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for IMS.Check BBLN's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while ETAO trades at $1.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas ETAO's P/E ratio is -0.01. In terms of profitability, IMS's ROE is +0.27%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, IMS is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for IMS.Check ETAO's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, BFRG has a market cap of 9.1M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while BFRG trades at $0.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas BFRG's P/E ratio is -1.07. In terms of profitability, IMS's ROE is +0.27%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, IMS is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for IMS.Check BFRG's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, MGRX has a market cap of 6.6M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while MGRX trades at $0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas MGRX's P/E ratio is -0.29. In terms of profitability, IMS's ROE is +0.27%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, IMS is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for IMS.Check MGRX's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while UPH trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas UPH's P/E ratio is -0.07. In terms of profitability, IMS's ROE is +0.27%, compared to UPH's ROE of -1.05%. Regarding short-term risk, IMS is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for IMS.Check UPH's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while UPH-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, IMS is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for IMS.Check UPH-WT's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while PEAR trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas PEAR's P/E ratio is -0.08. In terms of profitability, IMS's ROE is +0.27%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, IMS is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for IMS.Check PEAR's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while PEARW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas PEARW's P/E ratio is -0.00. In terms of profitability, IMS's ROE is +0.27%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, IMS is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for IMS.Check PEARW's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while OTRK trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas OTRK's P/E ratio is -0.02. In terms of profitability, IMS's ROE is +0.27%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, IMS is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for IMS.Check OTRK's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CMAX trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas CMAX's P/E ratio is -0.00. In terms of profitability, IMS's ROE is +0.27%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, IMS is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for IMS.Check CMAX's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, BFRGW has a market cap of 1.4M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while BFRGW trades at $0.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas BFRGW's P/E ratio is -0.92. In terms of profitability, IMS's ROE is +0.27%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, IMS is less volatile compared to BFRGW. This indicates lower risk in terms of short-term price fluctuations for IMS.Check BFRGW's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while LIFWZ trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, IMS is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for IMS.Check LIFWZ's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, ACON has a market cap of 1.2M. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while ACON trades at $2.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas ACON's P/E ratio is -0.25. In terms of profitability, IMS's ROE is +0.27%, compared to ACON's ROE of -0.59%. Regarding short-term risk, IMS is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for IMS.Check ACON's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, HCTI has a market cap of 990.8K. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while HCTI trades at $0.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas HCTI's P/E ratio is -0.11. In terms of profitability, IMS's ROE is +0.27%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, IMS is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for IMS.Check HCTI's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while VSEEW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, IMS's ROE is +0.27%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, IMS is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for IMS.Check VSEEW's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while MSPRZ trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, IMS is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for IMS.Check MSPRZ's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, VSEE has a market cap of 249.7K. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while VSEE trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas VSEE's P/E ratio is -0.03. In terms of profitability, IMS's ROE is +0.27%, compared to VSEE's ROE of -4.01%. Regarding short-term risk, IMS is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for IMS.Check VSEE's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while KERN trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas KERN's P/E ratio is -0.01. In terms of profitability, IMS's ROE is +0.27%, compared to KERN's ROE of -0.20%. Regarding short-term risk, IMS is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for IMS.Check KERN's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while KERNW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas KERNW's P/E ratio is -0.00. In terms of profitability, IMS's ROE is +0.27%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, IMS is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for IMS.Check KERNW's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while LIFWW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas LIFWW's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, IMS is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for IMS.Check LIFWW's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CMAXW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas CMAXW's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, IMS is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for IMS.Check CMAXW's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, ZCMD has a market cap of 30.7K. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while ZCMD trades at $0.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, IMS's ROE is +0.27%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, IMS is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for IMS.Check ZCMD's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, ACONW has a market cap of 13.8K. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while ACONW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas ACONW's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, IMS is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for IMS.Check ACONW's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, NAVA has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while NAVA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas NAVA's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, IMS is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for IMS.Check NAVA's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, CSLT has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CSLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas CSLT's P/E ratio is -37.27. In terms of profitability, IMS's ROE is +0.27%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, IMS is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for IMS.Check CSLT's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CHNGU trades at $73.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas CHNGU's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, IMS is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for IMS.Check CHNGU's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, CERN has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CERN trades at $94.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas CERN's P/E ratio is 55.84. In terms of profitability, IMS's ROE is +0.27%, compared to CERN's ROE of +0.14%. Regarding short-term risk, IMS is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for IMS.Check CERN's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while SMFRW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas SMFRW's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, IMS is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for IMS.Check SMFRW's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, CHNG has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CHNG trades at $27.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas CHNG's P/E ratio is -152.72. In terms of profitability, IMS's ROE is +0.27%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, IMS is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for IMS.Check CHNG's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while MSPRV trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas MSPRV's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to MSPRV's ROE of N/A. Regarding short-term risk, IMS is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for IMS.Check MSPRV's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, MTBC has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while MTBC trades at $3.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas MTBC's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, IMS is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for IMS.Check MTBC's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while MTBCO trades at $25.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas MTBCO's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, IMS is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for IMS.Check MTBCO's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while MTBCP trades at $26.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas MTBCP's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, IMS is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for IMS.Check MTBCP's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, CNVY has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while CNVY trades at $10.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas CNVY's P/E ratio is -71.50. In terms of profitability, IMS's ROE is +0.27%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, IMS is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for IMS.Check CNVY's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, NH has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while NH trades at $1.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas NH's P/E ratio is -0.12. In terms of profitability, IMS's ROE is +0.27%, compared to NH's ROE of +0.35%. Regarding short-term risk, IMS is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for IMS.Check NH's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, KURIU has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while KURIU trades at $9.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas KURIU's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, IMS is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for IMS.Check KURIU's competition here

IMS Health Holdings, Inc. (NYSE: IMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IMS stands at 0. In comparison, AFFX has a market cap of 0. Regarding current trading prices, IMS is priced at $31.34 on the NYSE, while AFFX trades at $14.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IMS currently has a P/E ratio of N/A, whereas AFFX's P/E ratio is N/A. In terms of profitability, IMS's ROE is +0.27%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, IMS is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for IMS.Check AFFX's competition here